--- title: "Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/302875802.md" description: "U.S. stock futures fell in Friday's pre-market session, led by Deckers Outdoor which dropped 9.1% after reporting mixed Q2 results and cutting FY27 guidance. Other major decliners included BayCom Corp (-11.4%), High Roller Technologies (-10.6%), Trulieve Cannabis (-7%), Five Point Holdings (-4.2%), Moderna (-4.1%), AT&T (-3.9%), SS&C Technologies (-3.5%), and Brown & Brown (-3.3%)." datetime: "2026-10-23T12:01:55.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/302875802.md) - [en](https://longbridge.com/en/news/302875802.md) - [zh-HK](https://longbridge.com/zh-HK/news/302875802.md) generator: "portal-rs" --- # Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures were lower this morning, with the Dow futures falling around 300 points on Friday. Shares of **Deckers Outdoor Corporation** (NYSE:DECK) fell sharply in pre-market trading after the company reported mixed second-quarter financial results and cut its FY27 sales guidance below estimates. Deckers Outdoor reported quarterly earnings of $2.31 per share, which beat the consensus estimate of $1.80, per Benzinga Pro data. Quarterly revenue of $1.48 billion missed the Street estimate of $1.51 billion. Deckers Outdoor shares dipped 9.1% to $77.50 in pre-market trading. Here are some other stocks moving lower in pre-market trading. - **BayCom Corp** (NASDAQ:BCML) tumbled 11.4% to $28.23 in pre-market trading after posting weak quarterly results. - **High Roller Technologies, Inc**. (NYSE:ROLR) fell 10.6% to $4.44 in pre-market trading. High Roller Technologies recently announced the commercial launch of its real-money prediction markets platform ROLR. - **Trulieve Cannabis Corp**. (NASDAQ:TRLV) dipped 7% to $10.16 in pre-market trading. - **Infosys Limited** (NYSE:INFY) fell 4.8% to $12.60 in pre-market trading. - **Five Point Holdings, LLC** (NYSE:FPH) dropped 4.2% to $4.3100 in pre-market trading after the company reported a year-over-year decrease in third-quarter EPS results. - **Moderna, Inc**. (NASDAQ:MRNA) declined 4.1% to $194.43 in pre-market trading after dipping around 18% on Thursday. - **AT&T Inc**. (NYSE:T) fell 3.9% to $21.87 in pre-market trading after gaining around 4% on Thursday. - S**S&C Technologies Holdings, In**c. (NASDAQ:SSNC) fell 3.5% to $86.44 in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter sales guidance with its midpoint below estimates. The company narrowed its FY26 guidance. - **Brown & Brown, Inc.** (NYSE:BRO) fell 3.3% to $72.02 in pre-market trading. *Photo via Shutterstock* ### Related Stocks - [BCML.US](https://longbridge.com/en/quote/BCML.US.md) - [BRO.US](https://longbridge.com/en/quote/BRO.US.md) - [DECK.US](https://longbridge.com/en/quote/DECK.US.md) - [FPH.US](https://longbridge.com/en/quote/FPH.US.md) - [INFY.US](https://longbridge.com/en/quote/INFY.US.md) - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) - [ROLR.US](https://longbridge.com/en/quote/ROLR.US.md) - [SSNC.US](https://longbridge.com/en/quote/SSNC.US.md) - [T.US](https://longbridge.com/en/quote/T.US.md) - [TRLV.US](https://longbridge.com/en/quote/TRLV.US.md) - [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md) - [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md) ## Related News & Research - [Moderna Stock Faces Dilution Risk and Downward Pressure From Convertible Note Conversions](https://longbridge.com/en/news/304753816.md) - [Moderna (MRNA) Q3 earnings report preview: what to look for](https://longbridge.com/en/news/304376611.md) - [Moderna, Inc. $MRNA Shares Newly Bought by Americana Partners LLC](https://longbridge.com/en/news/303850574.md) - [MRNA: Revenue growth and pipeline progress lift guidance as earnings return to profit](https://longbridge.com/en/news/304631717.md) - [Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study | MRNA Stock News](https://longbridge.com/en/news/304313330.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**